Concepedia

Nahoko Kaniwa

NK

Statistics

Publications

75

Citations

4.5K

H-Index

36

Active since

1982

Affiliations

National Institute of Health Sciences(Current)

National Cancer Center Hospital East

Tokyo Women's Medical University

National Cancer Center

National Cancer Research Institute

Nahoko Kaniwa is an author at National Institute of Health Sciences specializing in pharmacogenetics, pharmacology, and medicine.

Publications per year

1982–2016

75

Publications

75

HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara et al. · Pharmacogenomics · 2008 · 408 citations

Life Sciences, Immunology, Pharmacology +10

Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions

Wen‐Hung Chung, Wan-Chun Chang, Yun-Shien Lee et al. · JAMA · 2014 · 291 citations

Medicine, Dermatology, Genetics +16

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

Hironobu Minami, Kimie Sai, Mayumi Saeki et al. · Pharmacogenetics and Genomics · 2007 · 288 citations

Medicine, Pharmacokinetics, Pharmacology +17

<i>HLA‐B*1511</i> is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara et al. · Epilepsia · 2010 · 230 citations

Life Sciences, Immunology, Pharmacology +15

Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism

Emiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim et al. · Journal of Clinical Oncology · 2006 · 187 citations

Medicine, Oncology, Pharmacology +16

1–5 of 75